Figures & data
Table 1. Primer sequence
Figure 1. Elevated circPIP5K1A and JAK1 but reduced miR-552-3p are presented in the serum sample of T2DM patients.
![Figure 1. Elevated circPIP5K1A and JAK1 but reduced miR-552-3p are presented in the serum sample of T2DM patients.](/cms/asset/37559a3a-7377-4586-885e-8445e470d065/kbie_a_2022076_f0001_oc.jpg)
Figure 2. Downregulated circPIP5K1A restrains the inflammation, oxidative damage, and apoptosis of INS-1 β cell induced via glycolipid toxicity.
![Figure 2. Downregulated circPIP5K1A restrains the inflammation, oxidative damage, and apoptosis of INS-1 β cell induced via glycolipid toxicity.](/cms/asset/2ba68070-2587-4c2f-acea-788dab6d7236/kbie_a_2022076_f0002_oc.jpg)
Figure 3. CircPIP5K1A adsorbs miR-552-3p in INS-1E cells.
![Figure 3. CircPIP5K1A adsorbs miR-552-3p in INS-1E cells.](/cms/asset/d7e5827b-c843-4b42-8da5-1a33465211f9/kbie_a_2022076_f0003_oc.jpg)
Figure 4. Downregulating miR-552-3p turns around that dissipative circPIP5K1A reduces the toxic effect of glycolipid toxicity on INS-1 β cell.
![Figure 4. Downregulating miR-552-3p turns around that dissipative circPIP5K1A reduces the toxic effect of glycolipid toxicity on INS-1 β cell.](/cms/asset/8f98989a-4937-4793-9eff-8349cedbf009/kbie_a_2022076_f0004_oc.jpg)
Figure 5. JAK1 acts as a targeted mRNA of miR-552-3p.
![Figure 5. JAK1 acts as a targeted mRNA of miR-552-3p.](/cms/asset/9063bbe3-0fef-4d85-9034-195d2f5ce0cf/kbie_a_2022076_f0005_oc.jpg)
Figure 6. MiR-552-3p refrains the inflammation, oxidative damage, and apoptosis of glycolipid toxicity-stimulated INS-1 β cells via targeting the JAK1-STAT3 pathway.
![Figure 6. MiR-552-3p refrains the inflammation, oxidative damage, and apoptosis of glycolipid toxicity-stimulated INS-1 β cells via targeting the JAK1-STAT3 pathway.](/cms/asset/6dd1061f-9266-4b16-ada0-ba91b4c384c2/kbie_a_2022076_f0006_oc.jpg)